Dr Saeed Shanehsazzadeh

Saeed Shanehsazzadeh, PhD

NIF fellow

Category: Academic Staff
Research profile: Click to view

Biography

Saeed Shanehsazzadeh, PhD, received his Ph.D. in medical physics from the Tehran University of Medical Sciences in 2013. In his post-doctoral career, he further specialized in nanoparticle tracer development and characterization and was able to make significant contributions in the field of antibody labelled radioisotopes. From more than 10 years of research work in international molecular imaging, nanomedicine and multidisciplinary medical sciences labs in Iran, Germany, Belgium (UMONS), Canada (USASK), Singapore (NUS) and Australia (SAHMRI), Saeed brings an impressive background into the UNSW node helping to bring MPI as a novel tracer imaging method to the next level. He so far published more than 50 papers.

Publications

Book Chapters

Lahooti A; Shanehsazzadeh S; Laurent S, 2018, 'Chapter 7 Dual-Modality Imaging', in Iron Oxide Nanoparticles for Biomedical Applications, Elsevier, pp. 165 - 196, http://dx.doi.org/10.1016/b978-0-08-101925-2.00006-1
Lahooti A; Shanehsazzadeh S; Laurent S, 2018, 'Dual-Modality Imaging', in Iron Oxide Nanoparticles for Biomedical Applications, Elsevier, pp. 165 - 196, http://dx.doi.org/10.1016/b978-0-08-101925-2.00006-1
View more
Laurent S; Lahooti A; Shanehsazzadeh S; Muller RN, 2017, 'Nano delivery systems', in Drug Delivery Systems, pp. 277 - 342, http://dx.doi.org/10.1142/9789813201057_0009

Conference Papers

Shanehsazzadeh S; Oghabian MA; Allen BJ; Amanlou M; Johari Daha F, 2013, 'Evaluating the effect of USPIO nanoparticles for 21 days post magnetic cell labeling', in IFMBE Proceedings, pp. 2204 - 2207, http://dx.doi.org/10.1007/978-3-642-29305-4_578
Shanehsazzadeh S; Oghabian MA; Lahooti A; Allen BJ, 2013, 'Development of ultra small super paramagnetic iron oxide nanoparticles labeled with Gallium 67 as a dual modality probe', in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, WILEY-BLACKWELL, pp. S236 - S236, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318694100237&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Lahooti A; Shanehsazzadeh S; Oghabian MA; Allen BJ, 2013, 'Assessment of human effective absorbed dose of Tc-99m-USPIO based on biodistribution rat data', in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, WILEY-BLACKWELL, pp. S258 - S258, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318694100259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Moghaddam AK; Jalilian AR; Hayati V; Shanehsazzadeh S; Dodangeh A, 2011, 'Evaluation And Calculation of Human absorbed dose of (201) Tl(III)-DTPA-HIgG based on biodistribution data in rats', in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, WILEY-BLACKWELL, pp. S347 - S347, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295901600347&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Shanehsazzadeh S; Jalilian A, 2009, 'DEVELOPMENT OF [67GA]-DTPA-GONADORELIN IN NORMAL RATS', in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, JOHN WILEY & SONS LTD, pp. S326 - S326, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000268724900327&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Journal articles

Li Z; Kovshova T; Malinovskaya J; Knoll J; Shanehsazzadeh S; Osipova N; Chernysheva A; Melnikov P; Gelperina S; Wacker MG, 2024, 'Blood-Nanoparticle Interactions Create a Brain Delivery Superhighway for Doxorubicin', International Journal of Nanomedicine, 19, pp. 2039 - 2056, http://dx.doi.org/10.2147/IJN.S440598
Kim Duong HT; Abdibastami A; Gloag L; Bongers A; Shanehsazzadeh S; Nelson M; Cousins A; Bayat N; McCalmont H; Lock RB; Sulway S; Biazick J; Justin Gooding J; Tilley RD; Gooding J, 2023, 'Small zinc doped iron oxide tracers for magnetic particle imaging', Journal of Magnetism and Magnetic Materials, 587, http://dx.doi.org/10.1016/j.jmmm.2023.171304
Villa Nova M; Lin TP; Shanehsazzadeh S; Jain K; Ng SCY; Wacker R; Chichakly K; Wacker MG, 2022, 'Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence', Frontiers in Digital Health, 4, http://dx.doi.org/10.3389/fdgth.2022.799341
Gao GF; Ashtikar M; Kojima R; Yoshida T; Kaihara M; Tajiri T; Shanehsazzadeh S; Modh H; Wacker MG, 2021, 'Predicting drug release and degradation kinetics of long-acting microsphere formulations of tacrolimus for subcutaneous injection', Journal of Controlled Release, 329, pp. 372 - 384, http://dx.doi.org/10.1016/j.jconrel.2020.11.055
Lahooti A; Shanehsazzadeh S; Laurent S, 2020, 'Preliminary studies of 68Ga-NODA-USPION-BBN as a dual-modality contrast agent for use in positron emission tomography/magnetic resonance imaging', Nanotechnology, 31, http://dx.doi.org/10.1088/1361-6528/ab4446
Sakhtianchi R; Darvishi B; Mirzaie Z; Dorkoosh F; Shanehsazzadeh S; Dinarvand R, 2019, 'Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents', Pharmaceutical Development and Technology, 24, pp. 1063 - 1075, http://dx.doi.org/10.1080/10837450.2019.1569678
Shanehsazzadeh S; Jalilian AR; Lahooti A; Geramifar P; Beiki D; Yousefnia H; Rabiee A; Mazidi M; Mirshojaei SF; Maus S, 2017, 'Preclinical evaluation of 68Ga-MAA from commercial available 99mTc-MAA Kit', Iranian Journal of Pharmaceutical Research, 16, pp. 1415 - 1423
Lahooti A; Sarkar S; Saligheh Rad H; Gholami A; Nosrati S; Muller RN; Laurent S; Grüttner C; Geramifar P; Yousefnia H; Mazidi M; Shanehsazzadeh S, 2017, 'PEGylated superparamagnetic iron oxide nanoparticles labeled with 68Ga as a PET/MRI contrast agent: a biodistribution study', Journal of Radioanalytical and Nuclear Chemistry, 311, pp. 769 - 774, http://dx.doi.org/10.1007/s10967-016-5058-0
Farzadniya A; Faeghi F; Shanehsazzadeh S, 2017, 'Quantitative Effect of Magnetic Field Strength on PEGylated Superparamagnetic Iron Oxide Nanoparticles', Applied Magnetic Resonance, 48, pp. 597 - 607, http://dx.doi.org/10.1007/s00723-017-0880-2
Nikzad M; Jalilian AR; Shirvani-Arani S; Arabieh M; Shanesazzadeh S; Golchoobian H, 2017, 'Development and assessment of Sm-153-zoledronate complex as a possible bone pain palliative agent', IRANIAN JOURNAL OF NUCLEAR MEDICINE, 25, pp. 81 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000405588100001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Hatamie S; Ahadian MM; Ghiass MA; Zad AI; Saber R; Parseh B; Oghabian MA; Shanehsazzadeh S, 2016, 'Graphene/cobalt nanocarrier for hyperthermia therapy and MRI diagnosis', COLLOIDS AND SURFACES B-BIOINTERFACES, 146, pp. 271 - 279, http://dx.doi.org/10.1016/j.colsurfb.2016.06.018
Hajesmaeelzadeh F; Shanehsazzadeh S; Grüttner C; Daha FJ; Oghabian MA, 2016, 'Effect of coating thickness of iron oxide nanoparticles on their relaxivity in the MRI', Iranian Journal of Basic Medical Sciences, 19, pp. 166 - 171
Mirsadeghi S; Shanehsazzadeh S; Atyabi F; Dinarvand R, 2016, 'Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process', Materials Science and Engineering C, 59, pp. 390 - 397, http://dx.doi.org/10.1016/j.msec.2015.10.026
Lahooti A; Sarkar S; Laurent S; Shanehsazzadeh S, 2016, 'Dual nano-sized contrast agents in PET/MRI: a systematic review', Contrast Media and Molecular Imaging, 11, pp. 428 - 447, http://dx.doi.org/10.1002/cmmi.1719
Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R, 2016, 'Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer', Colloids and Surfaces B: Biointerfaces, 143, pp. 224 - 232, http://dx.doi.org/10.1016/j.colsurfb.2016.02.058
Nosrati S; Shanehsazzadeh S; Yousefnia H; Gholami A; Grüttner C; Jalilian AR; Hosseini RH; Lahooti A, 2016, 'Biodistribution evaluation of 166Ho–DTPA–SPION in normal rats', Journal of Radioanalytical and Nuclear Chemistry, 307, pp. 1559 - 1566, http://dx.doi.org/10.1007/s10967-015-4251-x
Yousefnia H; Zolghadri S; Sadeghi HR; Naderi M; Jalilian AR; Shanehsazzadeh S, 2016, 'Preparation and biological assessment of 177Lu-BPAMD as a high potential agent for bone pain palliation therapy: comparison with 177Lu-EDTMP', Journal of Radioanalytical and Nuclear Chemistry, 307, pp. 1243 - 1251, http://dx.doi.org/10.1007/s10967-015-4225-z
Shanehsazzadeh S; Grüttner C; Yousefnia H; Lahooti A; Gholami A; Nosrati S; Zolghadri S; Anijdan SHM; Lotfabadi A; Varnamkhasti BS; Daha FJ; Jalilian AR, 2016, 'Development of 177Lu-DTPA-SPIO conjugates for potential use as a dual contrast SPECT/MRI imaging agent', Radiochimica Acta, 104, pp. 337 - 344, http://dx.doi.org/10.1515/ract-2015-2499
Fazaeli Y; Shanehsazzadeh S; Lahooti A; Feizi S; Jalilian A, 2016, 'Preclinical dosimetric estimation of [111In] 5, 10, 15, 20-tetra phenyl porphyrin complex as a possible imaging/PDT agent', Radiochimica Acta, 104, pp. 327 - 336, http://dx.doi.org/10.1515/ract-2015-2444
Shanehsazzadeh S; Yousefnia H; Jalilian AR; Zolghadri S; Lahooti A, 2015, 'Estimated human absorbed dose for 68Ga-ECC based on mice data: comparison with 67Ga-ECC', Annals of Nuclear Medicine, 29, pp. 475 - 481, http://dx.doi.org/10.1007/s12149-015-0967-5
Fakhari A; Jalilian AR; Yousefnia H; Shanehsazzadeh S; Bahrami-Samani A; Johari-Daha F; Shafiee-Ardestani M; Khalaj A, 2015, 'Preparation, Biological Evaluation and Dosimetry Studies of Yb-175-Bis-Phosphonates for Palliative Treatment of Bone Pain', MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 24, pp. 110 - 119, http://dx.doi.org/10.4274/mirt.36036
Yousefnia H; Zolghadri S; Shanehsazzadeh S, 2015, 'Estimated human absorbed dose of 177Lu-BPAMD based on mice data: Comparison with 177Lu-EDTMP', Applied Radiation and Isotopes, 104, pp. 128 - 135, http://dx.doi.org/10.1016/j.apradiso.2015.06.033
Sadeghzadeh M; Shanehsazzadeh S; Lahooti A, 2015, 'Assessment of the effective absorbed dose of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl)piperidine in humans on the basis of biodistribution data of rats', Nuclear Medicine Communications, 36, pp. 90 - 94, http://dx.doi.org/10.1097/MNM.0000000000000210
Najafian N; Shanehsazzadeh S; Hajesmaeelzadeh F; Lahooti A; Gruettner C; Oghabian MA, 2015, 'Effect of Functional Group and Surface Charge of PEG and Dextran-Coated USPIO as a Contrast Agent in MRI on Relaxivity Constant', Applied Magnetic Resonance, 46, pp. 685 - 692, http://dx.doi.org/10.1007/s00723-015-0667-2
Shanehsazzadeh S; Yousefnia H; Lahooti A; Zolghadri S; Jalilian AR; Afarideh H, 2015, 'Assessment of human effective absorbed dose of 67 Ga–ECC based on biodistribution rat data', Annals of Nuclear Medicine, 29, pp. 118 - 124, http://dx.doi.org/10.1007/s12149-014-0917-7
Shanehsazzadeh S; Gruettner C; Lahooti A; Mahmoudi M; Allen BJ; Ghavami M; Daha FJ; Oghabian MA, 2015, 'Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo', Contrast Media and Molecular Imaging, 10, pp. 225 - 236, http://dx.doi.org/10.1002/cmmi.1627
Shanehsazzadeh S; Lahooti A; Hajipour MJ; Ghavami M; Azhdarzadeh M, 2015, 'External magnetic fields affect the biological impacts of superparamagnetic iron nanoparticles', Colloids and Surfaces B: Biointerfaces, 136, pp. 1107 - 1112, http://dx.doi.org/10.1016/j.colsurfb.2015.11.028
Shanehsazzadeh S; Lahooti A; Shirmardi SP; Erfani M, 2015, 'Comparison of estimated human effective dose of 67Ga- and 99mTc-labeled bombesin based on distribution data in mice', Journal of Radioanalytical and Nuclear Chemistry, 305, pp. 513 - 520, http://dx.doi.org/10.1007/s10967-015-3995-7
Shanehsazzadeh S; Lahooti A; Yousefnia H; Geramifar P; Jalilian AR, 2015, 'Comparison of estimated human dose of 68Ga-MAA with 99mTc-MAA based on rat data', Annals of Nuclear Medicine, 29, pp. 745 - 753, http://dx.doi.org/10.1007/s12149-015-0997-z
Shanehsazzadeh S; Lahooti A, 2014, 'Biodistribution of 80 nm iron oxide nanoparticles labeled with Tc-99m in Balb/c mice', NUCLEAR MEDICINE AND BIOLOGY, 41, pp. 625 - 625, http://dx.doi.org/10.1016/j.nucmedbio.2014.05.094
Omid H; Oghabian MA; Ahmadi R; Shahbazi N; Hosseini HRM; Shanehsazzadeh S; Zangeneh RN, 2014, 'Synthesizing and staining manganese oxide nanoparticles for cytotoxicity and cellular uptake investigation', Biochimica et Biophysica Acta - General Subjects, 1840, pp. 428 - 433, http://dx.doi.org/10.1016/j.bbagen.2013.10.001
Oghabian MA; Gharehaghaji N; Masoudi A; Shanehsazzadeh S; Ahmadi R; Majidi RF; Hosseini HRM, 2013, 'Effect of Coating Materials on Lymph Nodes Detection Using Magnetite Nanoparticles', Advanced Science, Engineering and Medicine, 5, pp. 37 - 45, http://dx.doi.org/10.1166/asem.2013.1214
Shanehsazzadeh S; Oghabian MA; Lahooti A; Abdollahi M; Abolghasem Haeri S; Amanlou M; Daha FJ; Allen BJ, 2013, 'Estimated background doses of [67Ga]-DTPA-USPIO in normal Balb/c mice as a potential therapeutic agent for liver and spleen cancers', Nuclear Medicine Communications, 34, pp. 915 - 925, http://dx.doi.org/10.1097/MNM.0b013e328362d2fb
Shanehsazzadeh S; Oghabian MA; Daha FJ; Amanlou M; Allen BJ, 2013, 'Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice', Journal of Radioanalytical and Nuclear Chemistry, 295, pp. 1517 - 1523, http://dx.doi.org/10.1007/s10967-012-2173-4
Lahooti A; Shanehsazzadeh S; Jalilian AR; Tavakoli MB, 2013, 'Assessment of effective absorbed dose of 111in-DTPA-buserelin in human on the basis of biodistribution rat data', Radiation Protection Dosimetry, 154, pp. 1 - 8, http://dx.doi.org/10.1093/rpd/ncs137
Shanehsazzadeh S; Oghabian MA; Allen BJ; Amanlou M; Masoudi A; Daha FJ, 2013, 'Evaluating the effect of ultrasmall superparamagnetic iron oxide nanoparticles for a long-term magnetic cell labeling', Journal of Medical Physics, 38, pp. 34 - 40, http://dx.doi.org/10.4103/0971-6203.106603
Jahanbakhsh R; Atyabi F; Shanehsazzadeh S; Sobhani Z; Adeli M; Dinarvand R, 2013, 'Modified Gadonanotubes as a promising novel MRI contrasting agent', DARU, Journal of Pharmaceutical Sciences, 21, http://dx.doi.org/10.1186/2008-2231-21-53
Shanehsazzadeh S; Lahooti A; Sadeghi HR; Jalilian AR, 2011, 'Estimation of human effective absorbed dose of 67Ga-cDTPA-gonadorelin based on biodistribution rat data', Nuclear Medicine Communications, 32, pp. 37 - 43, http://dx.doi.org/10.1097/MNM.0b013e328340b916
Amanlou M; Siadat SD; Ebrahimi SES; Alavi A; Aghasadeghi MR; Ardestani MS; Shanehsaz S; Ghorbani M; Mehravi B; Shafiee Alavidjeh M; Jabbari-Arabzadeh A; Abbasi M, 2011, 'Gd(3+)-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent.', International journal of nanomedicine, 6, pp. 747 - 763
Moghaddam AK; Jalilian AR; Hayati V; Shanehsazzadeh S, 2010, 'Determination of human absorbed dose of 201Tl(III)-DTPA-HIgG based on biodistribution data in rats', Radiation Protection Dosimetry, 141, pp. 269 - 274, http://dx.doi.org/10.1093/rpd/ncq172
Jalilian AR; Shanehsazzadeh S; Akhlaghi M; Kamali-Dehghan M; Moradkhani S, 2010, 'Development of [111In]-DTPA-buserelin for GnRH receptor studies', Radiochimica Acta, 98, pp. 113 - 119, http://dx.doi.org/10.1524/ract.2010.1689
Shanehsazzadeh S; Jalilian AR; Sadeghi HR; Allahverdi M, 2009, 'Determination of human absorbed dose of 67GA-DTPA-ACTH based on distribution data in rats', Radiation Protection Dosimetry, 134, pp. 79 - 86, http://dx.doi.org/10.1093/rpd/ncp085
Jalilian AR; Sardari D; Kia L; Rowshanfarzad P; Garousi J; Akhlaghi M; Shanehsazzadeh S; Mirzaii M, 2008, 'Preparation, quality control and biodistribution studies of two [ 111In]-rituximab immunoconjugates', Scientia Pharmaceutica, 76, pp. 151 - 170, http://dx.doi.org/10.3797/scipharm.0804-07
Jalilian AR; Shanehsazzadeh S; Akhlaghi M; Garoosi J; Rajabifar S; Tavakoli MB, 2008, 'Preparation and evaluation of [67Ga]-DTPA-β-1-24- corticotrophin in normal rats', Radiochimica Acta, 96, pp. 435 - 439, http://dx.doi.org/10.1524/ract.2008.1512
JALILIAN AR; SHANESAZZADEH S; ROWSHANFARZAD P; BOLOURINOVIN F; MAJDABADI A, 2008, 'Biodistribution study of [61Cu]pyruvaldehyde-bis (N-4-methylthiosemicarbazone) in normal rats as a PET tracer', Nuclear Science and Techniques/Hewuli, 19, pp. 159 - 164, http://dx.doi.org/10.1016/S1001-8042(08)60043-3
Jalilian AR; Shanehsazzadeh S; Akhlaghi M; Garousi J; Rajabifar S; Tavakoli MB, 2008, 'Preparation and biodistribution of [67Ga]-DTPA-gonadorelin in normal rats', Journal of Radioanalytical and Nuclear Chemistry, 278, pp. 123 - 129, http://dx.doi.org/10.1007/s10967-007-7241-9
Salamat MR; Rostampour N; Shanehsazzadeh S; Tavakoli MB; Siavash M; Almasi T, 2008, 'Assessment of bone mineral density with dual energy X-ray absorptiometry in pre- and post-menopausal women', Iranian Journal of Radiation Research, 6, pp. 107 - 111
Shanehsaz Zadeh S; Salehi A; Mehri A, 2007, 'Comparison of different invasive types of refractive errors operation', Journal of Isfahan Medical School, 24

Other

Shanehsazzadeh S; lahooti A; Babyn PS, 2021, "Prognostic value of radiomics parameters of PET/CT in patients with oropharyngeal carcinoma: A systematic review and meta- analysis", , http://dx.doi.org/10.13140/RG.2.2.26494.10569
Shanehsazzadeh S; lahooti A, 2021, "Prognostic value of radiomics parameters of PET/CT in patients with oropharyngeal carcinoma: A systematic review and meta- analysis", , http://dx.doi.org/10.13140/RG.2.2.26494.10569
View less